These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 4040369)

  • 1. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.
    Hamilton TC; Winker MA; Louie KG; Batist G; Behrens BC; Tsuruo T; Grotzinger KR; McKoy WM; Young RC; Ozols RF
    Biochem Pharmacol; 1985 Jul; 34(14):2583-6. PubMed ID: 4040369
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF
    Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular glutathione levels and sensitivity to radiation and antineoplastic agents in human ovarian cancer.
    Ozols RF; Hamilton TC; Young RC
    Prog Clin Biol Res; 1988; 276():287-93. PubMed ID: 3174681
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
    Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
    Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic reversal of drug resistance in ovarian cancer.
    Ozols RF
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):7-11. PubMed ID: 4048979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine. Correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitro.
    Jevtović-Todorović V; Guenthner TM
    Biochem Pharmacol; 1992 Oct; 44(7):1383-93. PubMed ID: 1417960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
    Ripple M; Mulcahy RT; Wilding G
    J Urol; 1993 Jul; 150(1):209-14. PubMed ID: 8510259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of drug resistance in human ovarian cancer: experimental results and clinical applications.
    Ozols RF; Hamilton TC; Young RC
    Prog Clin Biol Res; 1986; 223():173-85. PubMed ID: 3809199
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between nuclear glutathione levels and resistance to melphalan in human ovarian tumour cells.
    Britten RA; Green JA; Broughton C; Browning PG; White R; Warenius HM
    Biochem Pharmacol; 1991 Feb; 41(4):647-9. PubMed ID: 1997012
    [No Abstract]   [Full Text] [Related]  

  • 11. [Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine].
    Kudoh K; Kita T; Hirata J; Ishii K; Hiramatsu H; Kikuchi Y; Nagata I
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jun; 46(6):525-32. PubMed ID: 8040625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P; Loh SY; Kelland LR; Harrap KR
    Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism.
    Medh RD; Gupta V; Awasthi YC
    Biochem Pharmacol; 1991 Jul; 42(2):439-41. PubMed ID: 1859455
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.
    Louie KG; Behrens BC; Kinsella TJ; Hamilton TC; Grotzinger KR; McKoy WM; Winker MA; Ozols RF
    Cancer Res; 1985 May; 45(5):2110-5. PubMed ID: 3986765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.
    Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE
    Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells.
    Hromas RA; Andrews PA; Murphy MP; Burns CP
    Cancer Lett; 1987 Jan; 34(1):9-13. PubMed ID: 3802072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
    Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
    Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin.
    Mutch DG; Herzog TJ; Chen CA; Collins JL
    Gynecol Oncol; 1992 Oct; 47(1):28-33. PubMed ID: 1427396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P; Valenti M; Kelland LR
    Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
    Mistry P; Kelland LR; Abel G; Sidhar S; Harrap KR
    Br J Cancer; 1991 Aug; 64(2):215-20. PubMed ID: 1892748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.